Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.

I-Li LaiJeng-Fu YouYih-Jong ChernWen-Sy TsaiJy-Ming ChiangPao-Shiu HsiehHsin-Yuan HungChien-Yuh YehSum-Fu ChiangCheng-Chou LaiRei-Ping TangJinn-Shiun ChenYu-Jen Hsu

Published in: World journal of surgical oncology (2019)

For patients who had mid and low rectal cancer in stage pT1/pT2 and intermediate pathological risk, LE with chemoradiation presents an alternative treatment option for selected patients.

Keyphrases

rectal cancer
locally advanced
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
squamous cell carcinoma
breast cancer risk